Similar to other cancers, PI3K/AKT/mTOR pathway is hyperactive in MCC and inhibition of this pathway has demonstrated significant anti-MCC effects in vitro and in vivo as reported in this study and by others26,27,47,49,58,59. This evidence concerns the gene PIK3CD and cancer.